DBV Technologies DBVT
NASDAQ DBVT
$13.47 -0.23 (-1.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

DBV Technologies (DBVT) EBT (2020 - 2026)

DBV Technologies (DBVT) posted EBT of -$50.2 million for Q2 2026, down 5.91% sequentially from -$47.4 million in Q1 2026, and down 20.1% YoY from -$62.8 million in Q2 2025.

Analysis

DBV Technologies (DBVT) EBT (2020 - 2026) Analysis & Trends

DBV Technologies has reported EBT for 7 years, with the latest figure at -$50.2 million in Q2 2026.

  • Quarterly EBT fell 20.1% year-over-year to -$50.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$175.2 million (down 43.21% YoY) and the FY2025 annual result came in at -$146.5 million, down 28.62% from the prior year.
  • EBT retreated to -$50.2 million in Q2 2026 per DBVT's latest filing, from -$47.4 million in the prior quarter.
  • Over five years, EBT peaked at -$11.2 million in Q4 2023 and troughed at -$50.2 million in Q2 2026.
  • A 5-year average of -$29.3 million and a median of -$27.2 million in 2024 frame the typical range for EBT.
  • The sharpest annual moves came in 2022 and 2023: EBT slumped 187.63% in 2022, then jumped 71.49% in 2023.
  • Over 5 years, EBT stood at -$39.3 million in 2022, then surged by 71.49% to -$11.2 million in 2023, then slumped by 105.58% to -$23.0 million in 2024, then plunged by 93.22% to -$44.5 million in 2025, then retreated by 12.92% to -$50.2 million in 2026.
  • According to Business Quant data, EBT over the past three periods registered -$50.2 million, -$47.4 million, and -$44.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 542.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -767.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 312.46 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 177.81 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -11.37 Mn
10 DBV Technologies 5.88 Bn 5.70 Bn - -50.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.20 Mn
Mar 31, 2026 -47.40 Mn
Dec 31, 2025 -44.46 Mn
Sep 30, 2025 -33.16 Mn
Jun 30, 2025 -41.80 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 -23.01 Mn
Sep 30, 2024 -30.44 Mn
Jun 30, 2024 -33.12 Mn
Mar 31, 2024 -27.30 Mn
Dec 31, 2023 -11.19 Mn
Sep 30, 2023 -16.74 Mn
Jun 30, 2023 -24.23 Mn
Mar 31, 2023 -20.56 Mn
Dec 31, 2022 -39.26 Mn
Sep 30, 2022 -17.29 Mn
Jun 30, 2022 -23.04 Mn
Mar 31, 2022 -16.62 Mn
Dec 31, 2021 -13.65 Mn
Sep 30, 2021 -24.03 Mn